Business Development & Strategic Outreach Intern
About the job
- Must hold independent authorization to work or intern in Singapore; eligible candidates include citizens, permanent residents, or candidates with a valid student pass permitting the internship.
- Be a recent university graduate or current postgraduate student; a science background in life sciences, biotechnology, biomedical engineering, or a related field is preferred.
- Be fluent in English and articulate in written and verbal communication.
- Have strong analytical and structured thinking, with the ability to synthesize research into clear, actionable summaries.
- Be proficient in PowerPoint, Excel, and Word, including building presentation decks and tracking tools from scratch.
- Be familiar with immunoassay platforms and their applications, and able to grasp diagnostic assay concepts quickly.
- Be self-directed, comfortable working in a small early-stage team, and discreet with sensitive partnership and commercial information.
- Identify and research targeted stakeholders across research institutions, government agencies, and private sector companies relevant to joint assay development.
- Build and maintain a structured outreach database with contact details, institutional priorities, and relevant technical focus areas.
- Draft outreach communications and coordinate meeting scheduling on behalf of the CEO.
- Shadow the CEO in stakeholder meetings and calls.
- Prepare meeting minutes and action item trackers following each engagement.
- Follow up on commitments and maintain a live status log across all active conversations.
- Prepare a weekly progress summary covering outreach volume, meetings held, and pipeline status.
- Maintain a running tracker of stakeholder engagement stage, next steps, and owner.
- Proactively flag stalled or high-priority items to the CEO.
- Prepare and update presentation slides for partner and stakeholder meetings.
- Support the development of one-pagers, briefing notes, and other collateral as needed.
- A science background in life sciences, biotechnology, biomedical engineering, or a related field.
About the company
ATUM Ventures identifies promising deep-tech technologies from research institutes and universities and builds startups around them in a hands-on, venture-building model. It assembles founding teams, provides initial capital, and offers ongoing operational support such as fundraising guidance, legal and compliance help, and go-to-market strategies. The firm operates mainly in Medtech, Energy, and Advanced Manufacturing and deepens value through technical and commercial due diligence to de-risk early entrepreneurship. Its approach includes market-expansion programs to help Southeast Asian entry, using Singapore as a gateway, and offers corporate partnerships, investor-aligned deal flow, and co-building opportunities. Overall, its goal is to create and scale commercially viable deep-tech companies by turning research into deployable businesses while reducing early-stage risk for founders.
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Get referred to ATUM Ventures
See people who can refer or advise you
Simplify's Take
What believers are saying
- The Dutch-Singapore Deep-Tech Expansion Programme 2026 brings qualified foreign startups into ATUM's network.
- Enterprise Singapore-supported partnerships strengthen credibility and distribution for ATUM's platform.
- ATUM's 11 active ventures and 25-plus launched ventures show repeatable execution and momentum.
What critics are saying
- Raise The Bar 2026 depends on finding TRL 5 founders willing to relocate to Singapore.
- Portfolio concentration in deep tech exposes ATUM to long development cycles and pilot failures.
- If venture-building deal flow dries up, ATUM becomes a service firm without defensible scaling power.
What makes ATUM Ventures unique
- ATUM Ventures combines venture building with pre-seed capital and operational support in Singapore.
- It targets deep-tech verticals: Energy, MedTech, and Advanced Manufacturing, not consumer startups.
- Its 80-plus venture-builder experience and market-expansion programs create a strong commercialization moat.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Company Equity
Company News
Keiron Printing Technologies, based in Eindhoven, Netherlands, has closed a €20.7 million Series A funding round. The company aims to solve solder paste printing issues, which cause over 70% of defects in the €600 billion global electronics assembly market. The round was co-led by Invest-NL, DeepTechXL and Waves Capital, with participation from Ramphastos Investments, ATUM Ventures, Cottonwood Technology Fund and TNO Ventures. Keiron's HF2 LiFT printer replaces traditional stencil printers, jet printers and inspection systems with a single digital, non-contact platform. The technology increases first-pass yield from approximately 60% to above 95%, doubles production uptime, and accelerates programming by 10 times. The solution particularly addresses challenges in next-generation AI hardware, where components with up to 10,000 interconnects exceed conventional printing capabilities.
Eindhoven-based deeptech company Keiron Printing Technologies has raised €20.7 million in Series A funding to scale its digital assembly technology for printed circuit boards. Invest-NL invested €6.9 million and acts as lead investor alongside DeepTechXL and Waves Capital. Ramphastos, TNO Ventures, ATUM Ventures, and Cottonwood also participated. Keiron developed a digital production method for applying solder paste to circuit boards, replacing traditional metal stencils. The technology enables direct, precise application without physical tooling. The funding will support customer validation, production scale-up of initial systems, and development of an international service organisation. The company previously received innovation credit from RVO. Keiron's technology addresses growing demand for flexible production as electronics manufacturing shifts towards smaller batches, more complex designs, and sustainable processes for Europe's high-tech industry.